REVB · ISSUER CIK 1810560
REVELATION BIOSCIENCES, INC.
Between Aug 1, 2026 and Oct 29, 2026, 5 REVELATION BIOSCIENCES, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Chief Executive Officer, Director | A · Grant | — | +208,076 | 422,814 | +97% | — | ||
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Director | A · Grant | — | +32,011 | 44,169 | +263% | — | ||
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Chief Financial Officer | G · Gift | — | −208,073 | 0 | -100% | — | ||
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Chief Financial Officer | G · Gift | — | +208,073 | 300,136 | +226% | — | ||
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Chief Financial Officer | A · Grant | — | +208,073 | 208,073 | New | — | ||
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Director | A · Grant | — | +32,011 | 44,839 | +250% | — | ||
| Aug 18, 202617:00 | Aug 17, 2026 | REVB | Director | A · Grant | — | +32,011 | 44,769 | +251% | — |